Insect sting allergy

David F Graft1

  • 1Asthma and Allergic Diseases, Park Nicollet Clinic, and Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN 55416, USA. graftd@parknicollet.com

Insights

Insect sting allergy immunotherapy (VIT) is a highly successful treatment, reducing severe reactions from 60% to under 2%. Ongoing research aims to improve diagnostic tests for predicting patient risk and guiding treatment duration.

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine

Background:

  • Insect sting allergy is a significant health concern.
  • Venom immunotherapy (VIT) has been a major advancement in allergy treatment over the last 30 years.

Purpose of the Study:

  • To highlight the success of VIT in reducing severe allergic reactions.
  • To identify areas for future research in insect sting allergy management.

Main Methods:

  • Review of historical data and clinical outcomes of VIT.
  • Analysis of current diagnostic and treatment protocols for insect sting allergy.

Main Results:

  • VIT dramatically reduces the risk of life-threatening reactions from approximately 60% to less than 2%.
  • VIT represents a major success story in the field of allergy.

Conclusions:

  • Venom immunotherapy is a highly effective treatment for insect sting allergy.
  • Further research is needed for definitive diagnostic tests to predict patient risk and optimize VIT duration.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...